2
Mar 2026
A new retrospective cohort study examining the impact of Minnesota's first-in-the-nation mandated universal newborn screening for congenital cytomegalovirus (cCMV) shows that universal screening significantly decreased the age at first audiology visit and increased identification of mild hearing loss in infants.
2
Mar 2026
Female sex hormones estrogen and progesterone fluctuate monthly across the menstrual cycle, affecting moods and energy levels.
2
Mar 2026
A study from researchers at the CU Anschutz Marcus Institute for Brain Health suggests that veterans with concussions may continue to show subtle but measurable brain function differences more than a decade after their injury.
2
Mar 2026
Poverty can affect babies' motor development as early as six months of age. This is the conclusion of the first Brazilian study to examine the quantity and quality of motor development month by month and its relationship with socioeconomic vulnerability during the first months of life.
2
Mar 2026
Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene expression.
2
Mar 2026
Elena Mainetto, from Radboud University, Margaret Westwater, from the University of Oxford, and colleagues at the University of Cambridge explored whether they could change how much people enjoy beverages containing sugar or artificial sweeteners by manipulating previous expectations about the drinks.
2
Mar 2026
People with alcohol use disorders tend to prioritize alcohol over alternative rewards, and the neural underpinnings of this are unclear.
2
Mar 2026
Ultrasound AI, a pioneer in artificial intelligence applications for medical imaging, today announced it has received FDA De Novo clearance for its flagship Delivery Date AI technology, a cloud-based SaMD that determines a Predicted Delivery Date (PDD) solely from standard ultrasound images and seamless integration into current OB/MFM prenatal visit workflows; PDD is provided in real-time for actionable decision-making by the clinical team.
2
Mar 2026
Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050.
2
Mar 2026
Weight-loss (GLP-1 mimicking) drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further life-threatening complications that affect up to half of all patients, according to a new study led by the University of Bristol and University College London.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
